291 related articles for article (PubMed ID: 19997625)
21. Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease.
Nall TA; Chappell KJ; Stoermer MJ; Fang NX; Tyndall JD; Young PR; Fairlie DP
J Biol Chem; 2004 Nov; 279(47):48535-42. PubMed ID: 15322074
[TBL] [Abstract][Full Text] [Related]
22. Dynamic Interactions of Post Cleaved NS2B Cofactor and NS3 Protease Identified by Integrative Structural Approaches.
Quek JP; Ser Z; Chew BLA; Li X; Wang L; Sobota RM; Luo D; Phoo WW
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891424
[TBL] [Abstract][Full Text] [Related]
23. Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor.
Martinez AA; Espinosa BA; Adamek RN; Thomas BA; Chau J; Gonzalez E; Keppetipola N; Salzameda NT
Eur J Med Chem; 2018 Sep; 157():1202-1213. PubMed ID: 30193218
[TBL] [Abstract][Full Text] [Related]
24. Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation.
Robin G; Chappell K; Stoermer MJ; Hu SH; Young PR; Fairlie DP; Martin JL
J Mol Biol; 2009 Feb; 385(5):1568-77. PubMed ID: 19059417
[TBL] [Abstract][Full Text] [Related]
25. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.
Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835
[TBL] [Abstract][Full Text] [Related]
26. Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMR.
Kang C; Gayen S; Wang W; Severin R; Chen AS; Lim HA; Chia CS; Schüller A; Doan DN; Poulsen A; Hill J; Vasudevan SG; Keller TH
Antiviral Res; 2013 Feb; 97(2):137-44. PubMed ID: 23211132
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
28. Structure-based mutagenesis identifies important novel determinants of the NS2B cofactor of the West Nile virus two-component NS2B-NS3 proteinase.
Radichev I; Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY
J Gen Virol; 2008 Mar; 89(Pt 3):636-641. PubMed ID: 18272753
[TBL] [Abstract][Full Text] [Related]
29. NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex.
Kim YM; Gayen S; Kang C; Joy J; Huang Q; Chen AS; Wee JL; Ang MJ; Lim HA; Hung AW; Li R; Noble CG; Lee le T; Yip A; Wang QY; Chia CS; Hill J; Shi PY; Keller TH
J Biol Chem; 2013 May; 288(18):12891-900. PubMed ID: 23511634
[TBL] [Abstract][Full Text] [Related]
30. Crystal structures of full length DENV4 NS2B-NS3 reveal the dynamic interaction between NS2B and NS3.
Phoo WW; El Sahili A; Zhang Z; Chen MW; Liew CW; Lescar J; Vasudevan SG; Luo D
Antiviral Res; 2020 Oct; 182():104900. PubMed ID: 32763315
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease.
Bera AK; Kuhn RJ; Smith JL
J Biol Chem; 2007 Apr; 282(17):12883-92. PubMed ID: 17337448
[TBL] [Abstract][Full Text] [Related]
32. A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease.
Brecher M; Li Z; Liu B; Zhang J; Koetzner CA; Alifarag A; Jones SA; Lin Q; Kramer LD; Li H
PLoS Pathog; 2017 May; 13(5):e1006411. PubMed ID: 28542603
[TBL] [Abstract][Full Text] [Related]
33. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
34. Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor.
Brinkworth RI; Fairlie DP; Leung D; Young PR
J Gen Virol; 1999 May; 80 ( Pt 5)():1167-1177. PubMed ID: 10355763
[TBL] [Abstract][Full Text] [Related]
35. Detection and in-cell selectivity profiling of the full-length West Nile virus NS2B/NS3 serine protease using membrane-anchored fluorescent substrates.
Condotta SA; Martin MM; Boutin M; Jean F
Biol Chem; 2010 May; 391(5):549-59. PubMed ID: 20302513
[TBL] [Abstract][Full Text] [Related]
36. Expression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B-NS3 junction region.
Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY
Protein Expr Purif; 2007 Apr; 52(2):334-9. PubMed ID: 17189703
[TBL] [Abstract][Full Text] [Related]
37. Structural characterization and polymorphism analysis of the NS2B-NS3 protease from the 2017 Brazilian circulating strain of Yellow Fever virus.
Noske GD; Gawriljuk VO; Fernandes RS; Furtado ND; Bonaldo MC; Oliva G; Godoy AS
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129521. PubMed ID: 31931019
[TBL] [Abstract][Full Text] [Related]
38. Generation and characterization of proteolytically active and highly stable truncated and full-length recombinant West Nile virus NS3.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
Protein Expr Purif; 2007 May; 53(1):87-96. PubMed ID: 17174105
[TBL] [Abstract][Full Text] [Related]
39. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
Niyomrattanakit P; Winoyanuwattikun P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
J Virol; 2004 Dec; 78(24):13708-16. PubMed ID: 15564480
[TBL] [Abstract][Full Text] [Related]
40. Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease.
Tomlinson SM; Watowich SJ
Biochemistry; 2008 Nov; 47(45):11763-70. PubMed ID: 18855422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
